PTC Therapeutics (PTCT) calls active on FDA approval of Sarepta's (SRPT) eteplirsen
Go back to PTC Therapeutics (PTCT) calls active on FDA approval of Sarepta's (SRPT) eteplirsen| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 24.86 -0.3 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.16 | 52 Week High | $35.40 | |||
| Open | $25.13 | 52 Week Low | $4.03 | |||
| Day High | $25.28 | P/E | 2.64 | |||
| Day Low | $24.52 | EPS | $9.40 | |||
| Volume | 264,832 | |||||
